Breaking News Instant updates and real-time market news.

PYPD

PolyPid

$15.35 /

-0.14 (-0.90%)

07:54
02/16/21
02/16
07:54
02/16/21
07:54

PolyPid announces 100th patient enrolled in SHIELD I Phase 3 trial

PolyPid announced that the 100th patient has been enrolled and randomized in the SHIELD I trial, the Company's first of two Phase 3 clinical trials for its lead product candidate, D-PLEX100, for the prevention of post-abdominal surgery incisional infections. SHIELD I is a prospective, multinational, multicenter, randomized, double blind Phase 3 trial designed to assess the efficacy and safety of D-PLEX100 in the prevention of incisional surgical site infections post-abdominal surgery. The primary endpoint of the trial is the combination of incisional SSIs and mortality rate as measured by the proportion of subjects with either an SSIs event, as determined by a blinded and independent adjudication committee, or mortality for any reason within 30 days post-surgery. The trial will enroll a minimum of 616 patients, with a maximum of about 900 patients, as defined by the adaptive study design, in more than 60 centers in the United States, Europe and Israel.

  • 26

    Jun

PYPD PolyPid
$15.35 /

-0.14 (-0.90%)

11/24/20 Raymond James
Raymond James upgrades PolyPid to Strong Buy after BTD for D-PLEX
11/24/20 Raymond James
PolyPid upgraded to Strong Buy from Outperform at Raymond James
08/10/20 Alliance Global Partners
PolyPid initiated with a Buy at Alliance Global Partners
07/21/20 Raymond James
PolyPid initiated with an Outperform at Raymond James

TODAY'S FREE FLY STORIES

Downgrade
Guggenheim downgrades Array to Neutral on rising estimate risk » 06:42
10/20/21
10/20
06:42
10/20/21
06:42
ARRY

Array Technologies

$20.41 /

+1.005 (+5.18%)

Guggenheim analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARRY Array Technologies
$20.41 /

+1.005 (+5.18%)

ARRY Array Technologies
$20.41 /

+1.005 (+5.18%)

05:35 Today Guggenheim
Array Technologies downgraded to Neutral from Buy at Guggenheim
10/14/21 Truist
Array Technologies initiated with a Hold at Truist
10/14/21 Truist
Array Technologies initiated with a Hold at Truist
08/26/21 Piper Sandler
Array Technologies price target raised to $18 from $17 at Piper Sandler
ARRY Array Technologies
$20.41 /

+1.005 (+5.18%)

  • 19
    Mar
  • 03
    Dec
ARRY Array Technologies
$20.41 /

+1.005 (+5.18%)

Downgrade
Guggenheim downgrades SolarEdge to Neutral on rising estimate risk » 06:41
10/20/21
10/20
06:41
10/20/21
06:41
SEDG

SolarEdge

$317.26 /

+11.51 (+3.76%)

Guggenheim analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SEDG SolarEdge
$317.26 /

+11.51 (+3.76%)

SEDG SolarEdge
$317.26 /

+11.51 (+3.76%)

05:33 Today Guggenheim
SolarEdge downgraded to Neutral from Buy at Guggenheim
09/30/21 BMO Capital
SolarEdge initiated with an Outperform at BMO Capital
08/31/21 Wolfe Research
SolarEdge initiated with an Outperform at Wolfe Research
08/24/21 GLJ Research
California data 'increasingly troubling' for SolarEdge, Enphase, says GLJ
SEDG SolarEdge
$317.26 /

+11.51 (+3.76%)

SEDG SolarEdge
$317.26 /

+11.51 (+3.76%)

SEDG SolarEdge
$317.26 /

+11.51 (+3.76%)

Downgrade
Guggenheim downgrades Shoals to Neutral on rising estimate risk » 06:41
10/20/21
10/20
06:41
10/20/21
06:41
SHLS

Shoals Technologies

$28.33 /

+0.7 (+2.53%)

Guggenheim analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHLS Shoals Technologies
$28.33 /

+0.7 (+2.53%)

SHLS Shoals Technologies
$28.33 /

+0.7 (+2.53%)

05:34 Today Guggenheim
Shoals Technologies downgraded to Neutral from Buy at Guggenheim
10/14/21 Truist
Shoals Technologies initiated with a Hold at Truist
10/14/21 Truist
Shoals Technologies initiated with a Hold at Truist
09/28/21 JPMorgan
Shoals management not seeing projects cancelled, says JPMorgan
SHLS Shoals Technologies
$28.33 /

+0.7 (+2.53%)

  • 15
    Jul
  • 27
    Jan
SHLS Shoals Technologies
$28.33 /

+0.7 (+2.53%)

Downgrade
Guggenheim downgrades First Solar to Neutral on rising estimate risk » 06:40
10/20/21
10/20
06:40
10/20/21
06:40
FSLR

First Solar

$108.19 /

+3.43 (+3.27%)

Guggenheim analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FSLR First Solar
$108.19 /

+3.43 (+3.27%)

FSLR First Solar
$108.19 /

+3.43 (+3.27%)

05:34 Today Guggenheim
First Solar downgraded to Neutral from Buy at Guggenheim
09/21/21 Morgan Stanley
First Solar shares pricing in too much 'policy optimism,' says Morgan Stanley
09/21/21 KeyBanc
First Solar initiated with a Sector Weight at KeyBanc
09/20/21 KeyBanc
First Solar initiated with a Sector Weight at KeyBanc
FSLR First Solar
$108.19 /

+3.43 (+3.27%)

  • 15
    Dec
FSLR First Solar
$108.19 /

+3.43 (+3.27%)

FSLR First Solar
$108.19 /

+3.43 (+3.27%)

FSLR First Solar
$108.19 /

+3.43 (+3.27%)

Recommendations
Dover price target raised to $193 from $176 at Baird » 06:39
10/20/21
10/20
06:39
10/20/21
06:39
DOV

Dover

$167.83 /

+0.975 (+0.58%)

Baird analyst Mircea…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOV Dover
$167.83 /

+0.975 (+0.58%)

DOV Dover
$167.83 /

+0.975 (+0.58%)

06:24 Today Citi
Dover price target raised to $196 from $185 at Citi
10/07/21 Wells Fargo
Dover initiated with an Underweight at Wells Fargo
10/07/21 Wells Fargo
Dover initiated with an Underweight at Wells Fargo
07/21/21 Deutsche Bank
Dover price target raised to $177 from $167 at Deutsche Bank
DOV Dover
$167.83 /

+0.975 (+0.58%)

DOV Dover
$167.83 /

+0.975 (+0.58%)

DOV Dover
$167.83 /

+0.975 (+0.58%)

Hot Stocks
Fulton Financial raises FY21 NII outlook to $655M-$665M from $640M-$660M » 06:38
10/20/21
10/20
06:38
10/20/21
06:38
FULT

Fulton Financial

$16.01 /

-0.015 (-0.09%)

Sees a negative provision…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FULT Fulton Financial
$16.01 /

-0.015 (-0.09%)

FULT Fulton Financial
$16.01 /

-0.015 (-0.09%)

04/07/21 Raymond James
Fulton Financial downgraded to Market Perform from Outperform at Raymond James
FULT Fulton Financial
$16.01 /

-0.015 (-0.09%)

Upgrade
Citi upgrades Thermo Fisher to Buy, says discount unwarranted » 06:38
10/20/21
10/20
06:38
10/20/21
06:38
TMO

Thermo Fisher

$592.15 /

+4.155 (+0.71%)

Citi analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TMO Thermo Fisher
$592.15 /

+4.155 (+0.71%)

TMO Thermo Fisher
$592.15 /

+4.155 (+0.71%)

06:34 Today Citi
Thermo Fisher upgraded to Buy from Neutral at Citi
10/14/21 Cowen
Thermo Fisher price target raised to $696 from $655 at Cowen
09/23/21 Goldman Sachs
Thermo Fisher upgraded to Conviction Buy from Buy at Goldman Sachs
09/23/21 Cowen
Thermo Fisher price target raised to $655 from $560 at Cowen
TMO Thermo Fisher
$592.15 /

+4.155 (+0.71%)

TMO Thermo Fisher
$592.15 /

+4.155 (+0.71%)

TMO Thermo Fisher
$592.15 /

+4.155 (+0.71%)

Periodicals
McDonald's pressed by China to expand renminbi payment system, FT reports » 06:38
10/20/21
10/20
06:38
10/20/21
06:38
MCD

McDonald's

$242.73 /

+0.385 (+0.16%)

China has asked…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MCD McDonald's
$242.73 /

+0.385 (+0.16%)

MCD McDonald's
$242.73 /

+0.385 (+0.16%)

10/14/21 Wells Fargo
McDonald's price target raised to $276 from $269 at Wells Fargo
10/05/21 Loop Capital
McDonald's initiated with a Buy at Loop Capital
10/05/21 Deutsche Bank
McDonald's price target raised to $265 ahead of Q3 at Deutsche Bank
10/05/21 Piper Sandler
Piper teen survey shows clothing outranked food for first time since 2014
MCD McDonald's
$242.73 /

+0.385 (+0.16%)

MCD McDonald's
$242.73 /

+0.385 (+0.16%)

MCD McDonald's
$242.73 /

+0.385 (+0.16%)

MCD McDonald's
$242.73 /

+0.385 (+0.16%)

Hot Stocks
China Yuchai subsidiary, Beijing Xing Shun Da Bus form powertrain systems JV » 06:37
10/20/21
10/20
06:37
10/20/21
06:37
CYD

China Yuchai

$13.11 /

-0.58 (-4.24%)

China Yuchai announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CYD China Yuchai
$13.11 /

-0.58 (-4.24%)

Recommendations
BNY Mellon price target raised to $62 from $57 at Barclays » 06:36
10/20/21
10/20
06:36
10/20/21
06:36
BK

BNY Mellon

$57.66 /

+0.27 (+0.47%)

Barclays analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BK BNY Mellon
$57.66 /

+0.27 (+0.47%)

BK BNY Mellon
$57.66 /

+0.27 (+0.47%)

09/15/21 Citi
BNY Mellon price target raised to $60 from $56 at Citi
07/20/21
Fly Intel: Top five analyst upgrades
07/20/21 Argus
BNY Mellon upgraded to Buy from Hold at Argus
07/20/21 Argus
BNY Mellon upgraded to Buy from Hold at Argus
BK BNY Mellon
$57.66 /

+0.27 (+0.47%)

BK BNY Mellon
$57.66 /

+0.27 (+0.47%)

BK BNY Mellon
$57.66 /

+0.27 (+0.47%)

Recommendations
Halliburton price target raised to $36 from $30 at Barclays » 06:36
10/20/21
10/20
06:36
10/20/21
06:36
HAL

Halliburton

/

+

Barclays analyst J. David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HAL Halliburton
/

+

HAL Halliburton
/

+

06:18 Today Citi
Halliburton price target raised to $30 from $28 at Citi
10/15/21 Northland
Northland would use potential weakness in oil services 'big 3' to add exposure
10/12/21 Coker Palmer
Halliburton upgraded to Outperform from Sector Perform at Coker Palmer
09/13/21 Citi
Citi positive on oilfield services, upgrades Liberty to Buy, RPC to Neutral
HAL Halliburton
/

+

HAL Halliburton
/

+

HAL Halliburton
/

+

HAL Halliburton
/

+

Recommendations
Netflix price target raised to $675 from $625 at Barclays » 06:36
10/20/21
10/20
06:36
10/20/21
06:36
NFLX

Netflix

$639.47 /

+1.62 (+0.25%)

Barclays analyst Kannan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

06:17 Today Deutsche Bank
Deutsche Bank downgrades Netflix on valuation, keeps $590 price target
06:11 Today Deutsche Bank
Netflix downgraded to Hold from Buy at Deutsche Bank
04:58 Today Piper Sandler
Netflix Q4 content slate 'still looks compelling,' says Piper Sandler
04:51 Today Pivotal Research
Netflix price target raised to $750 from $700 at Pivotal Research
NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

Hot Stocks
Roche now sees FY21 sales up in mid-single digit range » 06:35
10/20/21
10/20
06:35
10/20/21
06:35
RHHBY

Roche

$48.55 /

-0.61 (-1.24%)

Sales are now expected to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$48.55 /

-0.61 (-1.24%)

RHHBY Roche
$48.55 /

-0.61 (-1.24%)

10/19/21 William Blair
William Blair says Atea MOONSONG results raise concerns, but plunge 'premature'
10/13/21 Morgan Stanley
Roche price target raised to CHF 380 from CHF 370 at Morgan Stanley
09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
RHHBY Roche
$48.55 /

-0.61 (-1.24%)

RHHBY Roche
$48.55 /

-0.61 (-1.24%)

RHHBY Roche
$48.55 /

-0.61 (-1.24%)

Hot Stocks
Tanzanian Gold provides update on Buckreef Gold's processing plant » 06:35
10/20/21
10/20
06:35
10/20/21
06:35
TRX

Tanzanian Gold

/

+

Tanzanian Gold is pleased…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRX Tanzanian Gold
/

+

TRX Tanzanian Gold
/

+

02/16/21 Alliance Global Partners
Tanzanian Gold initiated with a Buy at Alliance Global Partners
Initiation
Quipt Home Medical initiated with a Buy at Benchmark » 06:35
10/20/21
10/20
06:35
10/20/21
06:35
QIPT

Quipt Home Medical

/

+

Benchmark analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QIPT Quipt Home Medical
/

+

QIPT Quipt Home Medical
/

+

QIPT Quipt Home Medical
/

+

Recommendations
Intuitive Surgical price target raised to $370 from $350 at Baird » 06:35
10/20/21
10/20
06:35
10/20/21
06:35
ISRG

Intuitive Surgical

/

+

, JNJ

Johnson & Johnson

$163.90 /

+3.77 (+2.35%)

Baird analyst Mike Polark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ISRG Intuitive Surgical
/

+

JNJ Johnson & Johnson
$163.90 /

+3.77 (+2.35%)

ISRG Intuitive Surgical
/

+

04:59 Today Piper Sandler
Intuitive Surgical price target raised to $330 from $323 at Piper Sandler
10/01/21 Citi
Intuitive Surgical downgraded to Neutral from Buy at Citi
09/10/21 Stifel
Intuitive Surgical CFO commentary suggests negative revenue impact, says Stifel
07/22/21 Deutsche Bank
Intuitive Surgical price target raised to $925 from $825 at Deutsche Bank
JNJ Johnson & Johnson
$163.90 /

+3.77 (+2.35%)

10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
10/04/21 Piper Sandler
Xencor price target raised to $75 from $63 at Piper Sandler
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
ISRG Intuitive Surgical
/

+

JNJ Johnson & Johnson
$163.90 /

+3.77 (+2.35%)

ISRG Intuitive Surgical
/

+

JNJ Johnson & Johnson
$163.90 /

+3.77 (+2.35%)

ISRG Intuitive Surgical
/

+

JNJ Johnson & Johnson
$163.90 /

+3.77 (+2.35%)

ISRG Intuitive Surgical
/

+

JNJ Johnson & Johnson
$163.90 /

+3.77 (+2.35%)

Hot Stocks
CGI Inc. acquires Cognicase Management Consulting, terms undisclosed » 06:35
10/20/21
10/20
06:35
10/20/21
06:35
GIB

CGI Inc.

$91.95 /

+1.08 (+1.19%)

CGI announced that it is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GIB CGI Inc.
$91.95 /

+1.08 (+1.19%)

GIB CGI Inc.
$91.95 /

+1.08 (+1.19%)

09/14/21
Fly Intel: Top five analyst downgrades
09/14/21 BofA
CGI Inc. downgraded to Underperform amid IT Services rebalancing at BofA
09/14/21 BofA
DXC Technology upgraded to Buy amid IT Services rebalancing at BofA
09/14/21 BofA
CGI Inc. downgraded to Underperform from Buy at BofA
GIB CGI Inc.
$91.95 /

+1.08 (+1.19%)

General news
Oil Action: » 06:35
10/20/21
10/20
06:35
10/20/21
06:35
$ECON

Economic Data

/

+

Oil Action: Oil prices…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Upgrade
Thermo Fisher upgraded to Buy from Neutral at Citi » 06:34
10/20/21
10/20
06:34
10/20/21
06:34
TMO

Thermo Fisher

$592.15 /

+4.155 (+0.71%)

Citi analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TMO Thermo Fisher
$592.15 /

+4.155 (+0.71%)

TMO Thermo Fisher
$592.15 /

+4.155 (+0.71%)

10/14/21 Cowen
Thermo Fisher price target raised to $696 from $655 at Cowen
09/23/21 Goldman Sachs
Thermo Fisher upgraded to Conviction Buy from Buy at Goldman Sachs
09/23/21 Cowen
Thermo Fisher price target raised to $655 from $560 at Cowen
09/22/21 KeyBanc
Stevanato Group price target raised to $32 from $27 at KeyBanc
TMO Thermo Fisher
$592.15 /

+4.155 (+0.71%)

TMO Thermo Fisher
$592.15 /

+4.155 (+0.71%)

TMO Thermo Fisher
$592.15 /

+4.155 (+0.71%)

Earnings
Roche reports 9M group sales CHF 46.68B vs. CHF 43.98B last year » 06:34
10/20/21
10/20
06:34
10/20/21
06:34
RHHBY

Roche

$48.55 /

-0.61 (-1.24%)

Group sales up 8% at…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$48.55 /

-0.61 (-1.24%)

RHHBY Roche
$48.55 /

-0.61 (-1.24%)

10/19/21 William Blair
William Blair says Atea MOONSONG results raise concerns, but plunge 'premature'
10/13/21 Morgan Stanley
Roche price target raised to CHF 380 from CHF 370 at Morgan Stanley
09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
RHHBY Roche
$48.55 /

-0.61 (-1.24%)

RHHBY Roche
$48.55 /

-0.61 (-1.24%)

RHHBY Roche
$48.55 /

-0.61 (-1.24%)

Recommendations
Fifth Third price target raised to $51 from $44 at Barclays » 06:34
10/20/21
10/20
06:34
10/20/21
06:34
FITB

Fifth Third

$43.92 /

-0.155 (-0.35%)

Barclays analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FITB Fifth Third
$43.92 /

-0.155 (-0.35%)

FITB Fifth Third
$43.92 /

-0.155 (-0.35%)

06:19 Today Citi
Fifth Third price target raised to $47 from $44 at Citi
07/19/21 Odeon Capital
Fifth Third downgraded to Hold from Buy at Odeon Capital
07/16/21 Citi
Fifth Third assumed with a Neutral at Citi
07/06/21 Keefe Bruyette
Fifth Third assumed with a Market Perform at Keefe Bruyette
FITB Fifth Third
$43.92 /

-0.155 (-0.35%)

FITB Fifth Third
$43.92 /

-0.155 (-0.35%)

FITB Fifth Third
$43.92 /

-0.155 (-0.35%)

Hot Stocks
SpringsWorks Therapeutics enters license agreement with Dana-Farber » 06:33
10/20/21
10/20
06:33
10/20/21
06:33
SWTX

SpringsWorks Therapeutics

$58.42 /

-0.27 (-0.46%)

SpringWorks Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SWTX SpringsWorks Therapeutics
$58.42 /

-0.27 (-0.46%)

SWTX SpringsWorks Therapeutics
$58.42 /

-0.27 (-0.46%)

09/08/21 JPMorgan
SpringsWorks price target raised to $105 from $97 at JPMorgan
07/21/21 H.C. Wainwright
SpringsWorks price target raised to $136 from $124 at H.C. Wainwright
07/20/21 Goldman Sachs
SpringsWorks Therapeutics price target raised to $123 from $107 at Goldman Sachs
03/30/21 JPMorgan
SpringsWorks Therapeutics added to Analyst Focus List at JPMorgan
SWTX SpringsWorks Therapeutics
$58.42 /

-0.27 (-0.46%)

  • 02
    Mar
Hot Stocks
Matrix Service awarded storage tank contract by Calumet Specialty Products » 06:33
10/20/21
10/20
06:33
10/20/21
06:33
MTRX

Matrix Service

$9.87 /

-0.27 (-2.66%)

, CLMT

Calumet Specialty Products

$10.28 /

-0.24 (-2.28%)

Matrix Service (MTRX)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTRX Matrix Service
$9.87 /

-0.27 (-2.66%)

MTRX Matrix Service
$9.87 /

-0.27 (-2.66%)

CLMT Calumet Specialty Products
$10.28 /

-0.24 (-2.28%)

10/14/21 Goldman Sachs
Calumet Specialty Products price target raised to $11 from $6 at Goldman Sachs
10/04/21 H.C. Wainwright
Calumet Specialty Products initiated with a Buy at H.C. Wainwright
03/24/21 Wells Fargo
Calumet Specialty Products upgraded to Overweight at Wells Fargo
03/24/21 Wells Fargo
Calumet Specialty upgraded to Overweight from Equal Weight at Wells Fargo
MTRX Matrix Service
$9.87 /

-0.27 (-2.66%)

CLMT Calumet Specialty Products
$10.28 /

-0.24 (-2.28%)

MTRX Matrix Service
$9.87 /

-0.27 (-2.66%)

CLMT Calumet Specialty Products
$10.28 /

-0.24 (-2.28%)

Upgrade
Cimc Enric upgraded to Buy from Neutral at Citi » 06:32
10/20/21
10/20
06:32
10/20/21
06:32
CIMEF

Cimc Enric

$1.21 /

+0.12 (+11.01%)

Citi analyst Jamie Wang…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Initiation
DD3 Acquisition Corp. II initiated with a Buy at Benchmark » 06:32
10/20/21
10/20
06:32
10/20/21
06:32
DDMX

DD3 Acquisition Corp. II

$9.92 /

-0.01 (-0.10%)

Benchmark analyst Mike…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DDMX DD3 Acquisition Corp. II
$9.92 /

-0.01 (-0.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.